INTRODUCTION
Chemokines control leukocyte migration during hematopoiesis, innate and adaptive immune responses and inflammation (1) (2) (3) (4) . They are divided into CXC, CC, C and CX 3 I-TAC, IP10 and Mig are three non-ELR CXC chemokines which are more closely related to each other than to any other chemokine with an amino acid sequence identity of about 40% (7) (8) (9) . They mainly attract activated T lymphocytes, preferentially of the Th1 phenotype, which express high levels of CXCR3 (10) (11) (12) . The involvement in Th1 responses is also supported by the observation that the production of all three ligands by blood and tissue cells is induced by interferon-γ, the typical Th1 cytokine (7, 13, 14) . For instance, IP10 is expressed and CXCR3-positive T lymphocytes accumulate at sites of Th1-type inflammation such as multiple sclerosis (15, 16) , rheumatoid arthritis (17) (18) (19) , psoriasis (20, 21) and sarcoidosis (22) . Recently, it has also been shown that IP10 and CXCR3 are critically involved in the development of acute allograft rejection. Cardiac by guest on September 28, 2017 http://www.jbc.org/ Downloaded from allograft survival was markedly prolonged by targeting either donor-derived IP10 production or CXCR3 expression on host leukocytes as shown in studies with IP10-or CXCR3-deficient mice and with animals treated with antibodies that neutralize IP10 or CXCR3 (23, 24) . In these various diseases, the expression of the CXCR3 ligands, in particular of IP10, correlates with the tissue infiltration of T lymphocytes suggesting that these ligands play an important role in the regulation of cell recruitment to sites of inflammation.
CXCR3 is expressed on a fraction of circulating blood T cells, B cells and NK cells (18) .
Blood T cells positive for CXCR3 are mostly CD45RO + memory cells which express high levels of β1 integrins (18) , and the CXCR3 + /CD4 + T cell subset is enriched for Th1 cells (25) . T cell activation enhances CXCR3 expression and chemotactic responsiveness (26, 27) . Th1 cell lines generated in vitro express higher levels of CXCR3 and migrate better to I-TAC, IP10 and Mig than Th2 cell lines (12, 17) suggesting that CXCR3 and its ligands are more active in the setting of Th1-driven inflammatory responses. In addition, CXCR3 has been reported to be expressed on plasmacytoid and myeloid dendritic cells (28, 29) , leukemic B cells (30, 31) , thymocyte subsets (32) and dividing microvascular endothelial cells (33, 34) .
We have recently shown that I-TAC, IP10 and Mig, besides being agonists for CXCR3, act as natural antagonists for CCR3, the receptor for eotaxin and several other CC chemokines (35) . They compete for the binding of eotaxin to CCR3 and inhibit CCR3- shown by NMR spectroscopy, the hydrophobic cleft, which is formed by the N-loop and 40s-loop region, may provide the basis for the ability of IP10 to bind to both CXCR3 and CCR3 (36) . In this study we have explored the structure-function relationship of the CXCR3 ligands, in particular of I-TAC which has highest affinity for CXCR3 and is the most potent agonist. We show that the NH 2 -terminus of I-TAC is important for the agonistic and antagonistic activity. The structural motifs responsible for the higher activity of I-TAC were determined with a series of synthesized I-TAC/IP10 hybrids. The data suggest that the differences in function of the CXCR3 ligands can be assigned to distinct regions and that these regions are interchangeable.
EXPERIMENTAL PROCEDURES
Chemokine synthesis. All chemokines and chemokine analogs were chemically synthesized using tBoc solid-phase chemistry (37) . They were purified by HPLC and analyzed by electrospray mass spectrometry. For each chemokine used, the mass determined by mass spectrometry corresponded to the expected value. Receptor internalization. Chemokine-induced internalization was assayed as described (42) . Briefly, CXCR3-B300-19 cells were incubated for 30 min at 37°C with increasing
concentrations of chemokines to be tested. After washing twice with PBS, surface-bound ligands were removed by exposure to 50 mM glycine buffer, pH 3.0, containing 100 mM NaCl for 1 min followed by washing with PBS. Receptor expression was then determined by flow cytometry using phycoerythrin (PE)-conjugated mouse monoclonal anti-CXCR3
antibody (1C6, BD PharMingen, San Jose, CA) and the relative fluorescence intensity was calculated (43) . CXCR3 internalization. The binding of chemokines leads to a rapid receptor internalization, which is not observed on binding of antagonists (35, 44, 45) . expression levels decreased to 25% and 55%, respectively. In contrast, no internalization was observed when the cells were exposed to I-TAC (4-73) and, as expected, to the inactive analog, I-TAC . Together with the functional data, these results show that I-TAC (4-73) lacks agonistic activity and acts as a pure antagonist.
RESULTS

Receptor binding and functional activity of N-terminal truncated I-TAC analogs.
CXCR3-B300-
Generation of I-TAC-like IP10.
Of the three CXCR3 ligands, I-TAC has highest receptor affinity and is the most potent agonist as shown by chemotaxis and [Ca 2+ ] i mobilization assays (7, 46) . As shown in Fig. 5A and B, I-TAC potently and fully displaced both In Ca 2+ mobilization assays using CXCR3-B300-19 cells (Fig. 5D ) and PHA and IL-2 activated T lymphocytes (data not shown), I-TAC was about 15-fold more potent than IP10 with EC 30 values of 2.1 ± 0.4 nM for I-TAC (n=3) and 31.9 ± 9.7 nM for IP10 (n=3).
I-TAC was also about 1.5-fold more efficacious than IP10 to mobilize calcium. All (61) by cleaving off the first two NH 2 -terminal residues.
Of the three CXCR3 ligands, I-TAC is the dominant agonist (7, 46) . It has a higher affinity for CXCR3 and is more potent and efficacious than IP10 and Mig to induce Ca The hybrid study also underscores the importance of the NH 2 -terminus of I-TAC. IP10
with the NH 2 -terminus of I-TAC (I-TAC-H1) had I-TAC-like activity. It was, however, somewhat less efficacious than I-TAC to induce Ca 2+ changes. Although the NH 2 -terminus is important for activity, amino acid substitutions are well tolerated within this region as shown by the data obtained with I-TAC carrying the NH 2 -terminus of IP10 (I-TAC-H3) and all the I-TAC analogs with the single amino acid substitutions. Altogether, these data show that both the NH 2 -terminus and N-loop region contribute to the higher receptor binding affinity and activity of I-TAC compared to IP10 and Mig, and suggest that these two domains are the major functional determinants.
The observation that I-TAC (4-73) bound to CXCR3, but did not induce any functional responses such as chemotaxis and Ca 2+ changes, and failed to induce receptor internalization suggests that it acts as a true antagonist. Internalization is an agonistdriven event due to the phosphorylation of the receptor by G protein-coupled receptor kinases and subsequent uptake in clathrin-coated pits (62, 63) . We found that the internalization correlates with the agonistic activity. The decrease in agonistic activity by sequential NH 2 -terminal truncation of I-TAC was closely accompanied by the decrease in receptor uptake. Consistent with these findings, I-TAC was shown to be more potent than IP10 and Mig to induce CXCR3 internalization (35, 64) . The lack of inducing receptor downregulation by antagonists obtained by the modification of the NH 2 -terminus of chemokines, was also observed with SDF-1 (P2G) which binds to CXCR4 (65) and I-TAC/EoH1 which binds to CCR3 (35) . Similarly, no internalization was induced by natural chemokines acting as antagonists including I-TAC, IP10 and Mig which bind to CCR3 (35) , eotaxin which binds to CCR2 (44), and MCP-3 which binds to CCR5 (45) .
Like the chemokine-based antagonists, small molecule antagonists were unable to downregulate chemokine receptors as shown for TAK-779 which binds to CCR5 (66) and for UCB35625 which binds to CCR1 and CCR3 (67) . These data indicate that, as a rule, the blockade of chemokine receptors by antagonists mainly depends on receptor occupancy.
In conclusion, CXCR3 is a unique chemokine receptor that selectively binds three closely related CXC chemokines and is expressed preferentially on Th1 lymphocytes. I-TAC, IP10 and Mig are unique in that they are all induced by the typical Th1 cytokine interferon-γ in wide variety of cells. Given these properties, it is clear that CXCR3 and its ligands are playing an important role in Th1-driven inflammatory and immune responses.
By studying the structure-function relationship of the ligands, we have identified a novel and potent antagonist, I-TAC (4-73) for CXCR3, and the structural domains which are responsible for the higher activity of I-TAC compared to IP10 and Mig. The antagonist is a valuable tool to study the function of CXCR3 in vivo and it may have the potential for therapeutic application in inflammatory diseases. by guest on September 28, 2017 
